Completed OBSERVATIONAL NCT07204847
Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI
Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI: a Prospective Real-world Study
Sponsor: University Hospital, Montpellier
Updated 1 time since 2025 Last updated: Sep 24, 2025 Started: Nov 1, 2023 Primary completion: May 1, 2025 Completion: Jun 20, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07204847, this observational or N/A phase trial focuses on NSTE-ACS (NSTEMI and UA) and NSTEMI and remains completed. Sponsored by University Hospital, Montpellier, it has been updated 1 time since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Montpellier
- University Hospital, Nīmes
Data source: University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .